Cognition Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CGTX research report →
About the company
Cognition Therapeutics, Inc. is a biopharmaceutical company in the clinical stage, focused on identifying and advancing small molecule treatments. The firm's research and development efforts are primarily directed towards age-related neurodegenerative conditions affecting the central nervous system, as well as retinal disorders.
- CEO
- Lisa Ricciardi
- IPO
- 2021
- Employees
- 25
- HQ
- Purchase, NY, US
Price Chart
- Market Cap
- $86.09M
- P/E
- -4.47
- P/S
- 0.00
- P/B
- 3.49
- EV/EBITDA
- -2.87
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -72.68%
- ROIC
- -141.04%
- Revenue
- $0 · 0.00%
- Net Income
- $-23,487,000 · 30.86%
- EPS
- $-0.32 · 62.35%
- Op Income
- $-47,799,000
- FCF YoY
- 13.66%
- 52W High
- $3.83
- 52W Low
- $0.43
- 50D MA
- $1.24
- 200D MA
- $1.33
- Beta
- 1.75
- Avg Volume
- 1.43M
Get TickerSpark's AI analysis on CGTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 17, 26 | Khattar Jack A. | other | 25,000 |
| Jun 17, 26 | Monia Brett P | other | 25,000 |
| Jun 17, 26 | Wallace Peggy | other | 25,000 |
| Jun 17, 26 | RICHSTONE ELLEN B | other | 25,000 |
| Jun 17, 26 | Fletcher Aaron G.L. | other | 25,000 |
| May 1, 26 | Doyle John Brendan | other | 8,567 |
| Apr 16, 26 | Doyle John Brendan | buy | 10,000 |
| Apr 16, 26 | Ricciardi Lisa | buy | 9,175 |
| Apr 16, 26 | Caggiano Anthony | buy | 10,000 |
| Feb 15, 26 | Ricciardi Lisa | other | 5,850 |
Our CGTX coverage
Recent articles, reports, and earnings notes.
No research on CGTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CGTX report →Similar companies
Peers in the same neighborhood.